好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Do Those with Neuro-Autoimmune Disease Carry a Higher Burden of Disease?
Autoimmune Neurology
P1 - Poster Session 1 (9:00 AM-5:00 PM)
024
To investigate the burden of disease and their prognosis amongst patients with neuro-autoimmune disease (NAD).
NAD has been shown to increase overall mortality and early death among patients. However, the overall burden of disease in NAD patients has not yet been fully characterized.
A retrospective analysis on 34464 patients hospitalized at a tertiary care center in a major metropolitan area was conducted. The outcomes compared included the prevalence of comorbidities, high risk comorbidities, and rheumatoid arthritis and/or lupus (RAL) among patients with and without neuro-autoimmune disease (NAD and nNAD). The outcomes of the initial disposition after discharge, length of hospital stay, ICU admission, and death among patients with comorbidities and with or without neuro-autoimmune disease (cNAD and cnNAD)  was also determined.

There is no significant difference in the level of  comorbidity (53% vs 54%) or high risk comorbidities (19% vs 24%) between patients in NAD and nNAD, respectively (p>0.05). 4.7% of NAD and 2.2% of nNAD patients had RAL (p<0.02). The mortality was 5% in cNAD and 4.3% in ncNAD (p>0.05). ICU admissions was 16% in cNAD and 20% in ncNAD (p>0.05). 42% of patients in cNAD and 72% in ncNAD were discharged home (p<0.0001). The average length of stay was 10 and 6.7 days for patients in cNAD and ncNAD, respectively (p<0.01).

These results suggest that NAD may not affect the overall burden of disease in patients but may increase the prevalence of RAL. Furthermore, comorbidity status may correlate with length of stay and disposition in patients with NAD.

Authors/Disclosures
Mohsen Ahmed (New Jersey Medical school)
PRESENTER 		Mr. Ahmed has nothing to disclose.
Afaaq Ahmed Mr. Ahmed has nothing to disclose.
Ronak U. Trivedi Mr. Trivedi has nothing to disclose.
Muhammed Ors Mr. Ors has nothing to disclose.
Nabeel Ahmed (Stony Brook University Hospital) Mr. Ahmed has nothing to disclose.
Nizar Souayah, MD, FAAN (NJMS) Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.